Christopher Anzalone, Arrowhead Pharmaceuticals CEO

Ar­row­head adds newest fa­cil­i­ty to its Mid­west hub in RNAi drug pro­duc­tion push

Ar­row­head Phar­ma­ceu­ti­cals has pur­chased 13 acres of land in Wis­con­sin’s Verona Tech­nol­o­gy Park and will build a 140,000-square-foot drug man­u­fac­tur­ing fa­cil­i­ty.

The com­pa­ny will spend be­tween $200 mil­lion and $250 mil­lion to build out the fa­cil­i­ties, and the site is ex­pect­ed to cre­ate an­oth­er 250 jobs for the re­gion. Con­struc­tion starts in Q1. Ar­row­head al­ready has op­er­a­tions in Madi­son, WI, about 10 miles away.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.